Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Muhammad, Mujammami"'
Autor:
Muhammad Mujammami, Refat M. Nimer, Maha Al Mogren, Reem Almalki, Mohamad S. Alabdaljabar, Hicham Benabdelkamel, Anas M. Abdel Rahman
Publikováno v:
ACS Omega, Vol 9, Iss 30, Pp 32873-32880 (2024)
Externí odkaz:
https://doaj.org/article/068e5078f9334fb8b3f049e860ba1f34
Autor:
Muhammad Mujammami, Mohamed Rafiullah, Khalid Akkour, Assim A. Alfadda, Afshan Masood, Salini Scaria Joy, Hani Alhalal, Maria Arafah, Eman Alshehri, Ibrahim O. Alanazi, Hicham Benabdelkamel
Publikováno v:
ACS Omega, Vol 9, Iss 4, Pp 4721-4732 (2024)
Externí odkaz:
https://doaj.org/article/988ee10d1ff841babe74cbcac13cf611
Autor:
Yazed AlRuthia, Khaled Hani Aburisheh, Sondus Ata, Raghad Bin Salleeh, Shahad B. Alqudhibi, Raghad B. Alqudhibi, Ziad Alkraidis, Hala Humood Alkhalaf, Abdulrahman Abdullah Almogirah, Muhammad Mujammami, Reem Al Khalifah
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102057- (2024)
Introduction: Semaglutide, a Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA), is often prescribed for managing type 2 diabetes, particularly in cases unresponsive to other hypoglycemic agents. Despite its popularity, the real-world efficacy and c
Externí odkaz:
https://doaj.org/article/c93a2c7825d641a49e8780e0cd56625e
Autor:
Refat M. Nimer, Mahmoud A. Alfaqih, Eman R. Shehabat, Muhammad Mujammami, Anas M. Abdel Rahman
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Type-2 diabetes mellitus (T2DM) therapy requires early diagnosis and complication avoidance. Unfortunately, current diagnostic markers do not meet these needs. Data-independent acquisition mass spectrometry (DIA-MS) offers a solution for cli
Externí odkaz:
https://doaj.org/article/4bd893854d4b4eae8d8642a323c2f9d4
Autor:
Khaled Aburisheh, Mohammad F. AlKheraiji, Saleh I. Alwalan, Arthur C. Isnani, Mohamed Rafiullah, Muhammad Mujammami, Assim A. Alfadda
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background QT prolongation increases cardiovascular mortality in diabetes. The risk factors for QT prolongation vary across different studies. There is no data on the QT prolongation in patients with diabetes from the Arab region, where diab
Externí odkaz:
https://doaj.org/article/e36e88d766ca42e0acb952c1f70c9212
Autor:
Muhammad Mujammami, Shereen M. Aleidi, Adriana Zardini Buzatto, Awad Alshahrani, Reem H. AlMalki, Hicham Benabdelkamel, Mohammed Al Dubayee, Liang Li, Ahmad Aljada, Anas M. Abdel Rahman
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1717 (2023)
Metformin is the first-line oral medication for treating type 2 diabetes mellitus (T2DM). In the current study, an untargeted lipidomic analytical approach was used to investigate the alterations in the serum lipidome of a cohort of 89 participants,
Externí odkaz:
https://doaj.org/article/37e64a59ad4a44f1999a44db94f78558
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveChronic hyperglycemia induces pathogenic changes in the vascular endothelium and leads to the development of microvascular complications in patients with type 2 diabetes mellitus. Early identification of markers of diabetes complications may
Externí odkaz:
https://doaj.org/article/86e0af22acc74362983845a971ad8a46
Autor:
Awad Alshahrani, Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, Mohthash Musambil, Ibrahim O. Alanazi, Mohammed Al Dubayee, Anas M. Abdel Rahman, Hicham Benabdelkamel
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1345 (2023)
Background: Obesity and type 2 diabetes mellitus (T2DM) are characterized by underlying low-grade chronic inflammation. Metformin has been used as the first line of therapy in T2DM as it decreases hepatic glucose production and glucose intestinal abs
Externí odkaz:
https://doaj.org/article/10f1ca8ffe2a4a2d8d6ccbcf2b96eff1
Autor:
Mohamed Abu-Farha, Shibu Joseph, Anwar Mohammad, Arshad Channanath, Ibrahim Taher, Fahd Al-Mulla, Muhammad Mujammami, Thangavel Alphonse Thanaraj, Jehad Abubaker, Anas M. Abdel Rahman
Publikováno v:
Metabolites, Vol 13, Iss 9, p 972 (2023)
ANGPTL8 is recognized as a regulator of lipid metabolism through its role in inhibiting lipoprotein lipase activity. ANGPTL8 gene variants, particularly rs2278426 leading to the R59W variant in the protein, have been associated with lipid traits in v
Externí odkaz:
https://doaj.org/article/402a915e472e4599a4b2a1caee19ea90
Publikováno v:
Diagnostics, Vol 13, Iss 10, p 1736 (2023)
(1) Background: Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease caused by the destruction of pancreatic insulin-producing beta cells. T1D is one of the most common endocrine and metabolic disorders occurring in children. Autoantibodies
Externí odkaz:
https://doaj.org/article/90d171f8c874424598a75f8f652d1234